![](https://www.orega-biotech.com/wp-content/uploads/2019/09/asco.jpg)
Meet us at the 2019 ASCO annual meeting in Chicago
17 June 2019![](https://www.orega-biotech.com/wp-content/uploads/2019/08/OB.jpg)
Dr Bonnefoy to inaugurate first CyTOF Hyperion in France
17 September 2019The publication of preclinical data of the CD39-blocking monoclonal antibody IPH5201 appears in the May 21, 2019 issue of the journal Cell Reports.
Read the full manuscript titled “Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies”